baber/WOPTO huggingface dataset:
Patent NZ-562369-A (NZ)
Title: Apparatus and method for applying solid edible particulates to an edible substrate
Inventor: LUDWICK RICHARD EUGENE
IPC: A21C9/04
Filed: 2006-04-06
Abstract: Disclosed is an apparatus and method for applying solid edible particulates to an exposed surface of an edible substrate. The apparatus includes a particulate supply, a metered dosing system, a conduit through which the measured particulates are to the edible substrate, an applicator nozzle to direct the measured particulates from the conduit onto the exposed surface of the substrate, and a vacuum system that supplies a directed stream of air to transfer the particulates from the dosing system through the conduit and the nozzle. The particulates are ejected at a velocity sufficient to cut through air currents between the nozzle and substrate, but insufficient to fully penetrate the exposed surface of the substrate, to deposit and adhere a substantial amount of the particulates in a desired pattern onto the exposed surface of the substrate.
Patent NZ-563444-A (NZ)
Title: Pyrrolo(2,3-b)pyridine derivatives as protein kinase inhibitors
Inventor: ZUCKERMAN REBECCA
IPC: A61K31/435
Filed: 2006-05-16
Abstract: Disclosed is a compounds of the pictured chemical structure, or a salt, tautomer, or stereoisomer thereof, where the substituents are as defined in the specification. Also disclosed is the use of the compound for treating a c-kit or c-fms mediated disease or condition, such as gastrointestinal stromal tumors, multiple myeloma, melanoma, breast cancer, renal hypertrophy, rheumatoid arthritis, multiple sclerosis, glomerulonephritis, interstitial nephritis, Lupus nephritis, tubular necrosis, and diabetes-associated renal complications.
Patent NZ-567980-A (NZ)
Title: Administration routes (intranasal or mucosal and parenteral or intramuscular) for priming/boosting with influenza vaccines
Inventor: VAJDY MICHAEL
IPC: A61K39/145
Filed: 2006-11-06
Abstract: Discloses the use of a live or inactivated influenza virus in the manufacture of a medicament for the prophylaxis or therapy of influenza according to a treatment regimen. The medicament treatment regime comprises (i) administration by an intranasal mucosal route and (ii) a secondary parenteral administration to a subject immunized previously by mucosal administration of the live or inactivated influenza virus. The therapeutic application is for the treatment of influenza.
Patent NZ-569018-A (NZ)
Title: Extraction of glucosinolates from plant material using anion exchange membranes
Inventor: WEST LESLIE GEORGE
IPC: A23L29/00
Filed: 2008-06-10
Abstract: Discloses a method of extracting glucosinolates from glucosinolate-containing plant material, said method comprising: (i) providing a mixture of glucosinolate-containing plant material and liquid; (ii) heating the mixture for a time and temperature sufficient to inactivate enzymes in the glucosinolate-containing plant material to form a heat inactivated mixture; (iii) contacting the heat inactivated mixture with an anion exchange membrane for about 4 to about 24 hours and a temperature of about 2 to about 7°C, whereby at least a portion of the glucosinolates are absorbed onto the anion exchange membrane; and (iv) contacting the anion exchange membrane having absorbed glucosinolates with an aqueous solution for a time sufficient to release the extracted glucosinolates from the anion exchange membrane to form an aqueous media containing the glucosinolates.
Patent NZ-571074-A (NZ)
Title: Apparatus for manufacturing a pipe with multiple layers including a middle layer of fused resin which has adjustable thickness
Inventor: PARK WOON YONG
IPC: B29C48/35
Filed: 2007-02-15
Abstract: Disclosed is an apparatus for manufacturing a pipe having multiple layers. The apparatus includes: a winder (60) having a cylindrical shape and a driving means (63) for rotating the winder; an internal (71) and an external (73) layer extruder for extruding resin into resin sheets to form an internal layer (51P) and an external layer (53P), respectively; a middle layer sheet supply device (72) for pulling out a middle layer sheet (52P) using a pair of rollers from fused material; and a pressure roller (65) for pressing a resultant structure, in which the sheets are wound around the winder. The middle layer sheet supply device includes: a tank (72A) in which fused resin for forming the middle layer sheet is stored; a pair of pulling rollers (72B) installed under the tank for pulling the fused resin by being rotated by the driving means; and a distance adjustment device for adjusting a distance between the pair of pulling rollers.
Patent NZ-572600-A (NZ)
Title: 6-Amino-purine derivatives for the treatment of cancer and fibrogenetic disorders
Inventor: BAJJI ASHOK C
IPC: C07D473/24
Filed: 2007-05-14
Abstract: Disclosed are 6-amino-purine derivatives as represented by the general Formula I or a pharmaceutically acceptable salt thereof, wherein: A is a substituted or unsubstituted benzo[1,3]dioxole group, indanone or indane group; B is a substituted or unsubstituted aryl, heteroaryl, heterocyclic, or carbocyclic group such as a piperidine, homopiperidine, piperazine, pyrrolidine or azetidine group; R1 is hydrogen, alkyl, aryl, heteroaryl, amino, or halo; and wherein the other substituents are as defined hererin. Of particular importance are the compounds 9-[2-(1-acetylpiperidin-4-yl)ethyl]-8-[(6-bromo-1,3-benzodioxol-5-yl)thio]-9H-purin-6-amine, 4-(2-{ 6-amino-8-[(6-bromo-1,3-benzodioxol-5-yl)thio]-9H-purin-9-yl} ethyl)piperidine-1-carbaldehyde, (2S)-1-[4-(2-{ 6-amino-8-[(6-bromo-1,3-benzodioxol-5-yl)thio]-9H-purin-9-yl} ethyl)piperidin-1-yl]-1-oxopropan-2-ol, 2-[4-(2-{ 6-amino-8-[(6-bromo-1,3-benzodioxol-5-yl)thio]-9H-purin-9-yl} ethyl)piperidin-1-yl]-2-oxoethanol, 6-({ 9-[2-(1-acetylpiperidin-4-yl)ethyl]-6-amino-9H-purin-8-yl} thio )-1,3-benzodioxole-5-carbonitrile, and (2R)-1-[4-(2-{ 6-amino-8-[(6-bromo-1,3-benzodioxol-5-yl)thio]-9H-purin-9-yl} ethyl)piperidin-1-yl]-1-oxopropan-2-ol. Further disclosed is a pharmaceutical composition comprising a compound as defined above for the treatment of a disorder chosen from inflammatory diseases, infections, autoimmune disorders, stroke, ischemia, cardiac disorders, neurological disorders, fibrogenetic disorders, proliferative disorders, tumors, leukemias, neoplasms, cancers, carcinomas, metabolic diseases, and malignant disease.
Patent NZ-572937-A (NZ)
Title: Solid oral dosage form of Aliskiren and hydrochlorothiazide which comprise a filler which is a mixture of wheat starch and lactose
Inventor: WILLMANN MATTHIAS
IPC: A61K9/20
Filed: 2007-06-21
Abstract: Disclosed is a solid oral dosage form which comprises: a) a therapeutically effective amount of Aliskiren, or a pharmaceutically acceptable salt thereof; b) a therapeutically effective amount of hydrochlorothiazide (HCTZ); and c) a hydrophilic filler, wherein the hydrophilic filler is a mixture of wheat starch and lactose; for the treatment of hypertension, congestive heart failure, angina, myocardial infarction, atherosclerosis, diabetic nephropathy, diabetic cardiac myopathy, renal insufficiency, peripheral vascular disease, left ventricular hypertrophy, cognitive dysfunction, stroke, headache and chronic heart failure.
Patent NZ-576432-A (NZ)
Title: Piperazinyl and diazapanyl benzamides and benzthioamides
IPC: A61P37/08
Filed: 2003-10-21
Abstract: Disclosed is a compound of formula (I) wherein n is 1 or 2, X is O or S; and wherein the rest of the substituents are disclosed in the specification; or a pharmaceutically acceptable salt, ester, tautomer, solvate or amide thereof. Also disclosed is the use of a compound of formula (I) in the preparation of a medicament for inhibiting histamine H3 receptor activity. (62) Divided Out of 562813
Patent NZ-578769-A (NZ)
Title: Load-bearing stuctural steel connection formed by clinching workpieces using conical die
Inventor: ISRAEL MARKUS
IPC: B21D39/03
Filed: 2008-02-08
Abstract: A method for the production of a load-bearing structural steel connection, wherein a clinching connection is formed by means of a male die (20) and a female die (30) using local deformation, the connection connecting a first metal workpiece (11) to a second metal workpiece (12). For this purpose, the first metal workpiece and the second metal workpiece are first placed on top of each other on a processing surface of the female die and aligned. Subsequently the die of the male die is applied and lowered into the two metal workpieces placed on top of each other until the clinching connection has been formed by plastic deformation. The first metal workpiece has a first workpiece thickness and the second metal workpiece has a second workpiece thickness that together result in a total workpiece thickness which is greater than 8 mm. The die is configured in a rotationally symmetrical manner with regard to the rotational axis (24) thereof and has a conically shaped transitional region tapering at an angle in the lowering direction of the die.
Patent NZ-582929-A (NZ)
Title: Derivatives of n-(arylamino) sulfonamides including polymorphs as inhibitors of mek as well as compositions, methods of use and methods for preparing the same
Inventor: VERNIER JEAN-MICHEL
IPC: A61K31/18
Filed: 2008-07-28
Abstract: Disclosed is the use of a compound of formula (I) where the substituents are as disclosed in the specification in the manufacture of a medicament. Particular compounds are N-(3,4,6-trifluoro-2-(2-fluoro-4-iodophenylamino)-phenyl)-1-(2,3-dihydroxypropyl) cyclopropane-1-sulfonamide and N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl) cyclopropane-1-sulfonamide. Also disclosed in the compound, composition, or polymorph comprising one of the particular compounds; a batch of tablets comprising a particular compound and a method of treating cancer or inhibiting MEK enzymes wherein the method is not in a human. The medicament is useful for inhibiting MEK enzymes as treating disorders such as stroke, cancer and inflammatory diseases.
Patent NZ-587111-A (NZ)
Title: Infusion part including seal between cannula and fluid inlet or outlet
Inventor: GYRN STEFFEN
IPC: A61M5/142
Filed: 2009-02-12
Abstract: An infusion part comprising a cannula part (7) and a fluid path, whereby a sealing (18) is positioned between the cannula part and the inlet/outlet opening (12) of the fluid path when the cannula part is in position for use in order to keep the fluid path to the cannula tight. The sealing is surrounding the inlet/outlet opening and/or the distance d1 between a centre line c of the cannula part and a point on the outer surface of the cannula part positioned at or above the upper edge of the sealing is larger than the distance d2 between the centre line c of the cannula part and a point on the outer surface of the cannula part positioned at or below the lower edge of the sealing.
Patent NZ-589360-A (NZ)
Title: Radiohalogen 18F substituted on a pyridine arboxamide compound
Inventor: KATSIFIS ANDREW
IPC: A61K51/04
Filed: 2009-04-22
Abstract: A compound comprising a pyridine carboxamide structure wherein an aromatic ring in the structure is substituted radio halogen atom 18F (fluorine) and wherein the substitution on the amide nitrogen atom is: a hydrogen atom and a tertiary aminoalkyl group; or such that the amide nitrogen is a member of a saturated ring structure having a second nitrogen atom in the ring; or a pharmaceutically acceptable salt of said compound. A structural representation of a possible compound is shown in formula (I). R3 and R4 can form an aryl ring fused to the pyridine ring. Also disclosed is a process for making a compound comprising the step of treating a precursor comprising a leaving group so as to replace said leaving group with the radiohalogen atom18F, said precursor comprising a pyridine carboxamide structure wherein an aromatic ring in the structure is substituted with said leaving group and wherein the substitution on the amide nitrogen atom is a hydrogen atom and a tertiary aminoalkyl group; or the process includes the step of treating a solution of a precursor comprising a chloro leaving group in dimethylformamide with K[18F]-K2.2.2 K2CO3, and heating the mixture at 150 degrees C for 10 minutes; said precursor comprising a pyridine carboxamide structure wherein an aromatic ring in the structure is substituted with said leaving group and wherein the substitution on the amide nitrogen atom is a hydrogen atom and a tertiary aminoalkyl group, such that the compound binds to melanin.
Patent NZ-589532-A (NZ)
Title: Diamino-pyridine, pyrimidine, and pyridazine modulators of the histamine H4 receptor
Inventor: CAI HUI
IPC: A01N43/58
Filed: 2009-06-11
Abstract: Disclosed are diamino-pyridine, pyrimidine, and pyridazine compounds of formula (I), wherein the substituents are disclosed within the specification, and a pharmaceutically acceptable salt and/or prodrug thereof. Examples of disclosed compounds of formula (I) include: Bicyclo[2.2.1]hept-2-yl-[4-((3R)-3-methylamino-pyrrolidin-1-yl)-pyridin-2-yl]-amine dihydrochloride; and N-(Cyclopropylmethyl)-4-[(3R)-3-(methylamino)pyrrolidin-1-yl]pyridin-2-amine ditrifluoroacetate; and 4-[(3R)-3-(Methylamino)pyrrolidin-1-yl]-N-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]pyridin-2-amine; and 4-Piperazin-1-yl-N-propylpyridin-2-amine dihydrochloride. Further disclosed is a composition comprising a compound of formula (I), and the use of a compound of formula (I) in the preparation of a medicament for treating a disease, disorder, or medical condition mediated by histamine H4 receptor activity, such as imflammatory disorders, allergic disorders, dermatological disorders, autoimmune disease, lymphatic disorders, and immunodeficiency disorders.
Patent NZ-599806-A (NZ)
Title: A building panel, building system and method of constructing a building
Inventor: NAIDOO KUBASHEN JEROME
IPC: E04G25/06
Filed: 2011-10-11
Abstract: A building system (10) comprising a building panel (12) is disclosed. The building panel comprises first and second outer sheet members (20, 22) and an inner sheet member (24) disposed between the first and second outer sheet members. A solid insulating material (26, 28) is disposed between the first and second outer sheet members and the inner sheet member. The building system further comprises first (14) and second (16) track members. The first track member is engagable with the building panel along a first side such that the first track member is connectable to the first and second outer sheet members. The second track member is engagable with the building panel along a second side such that the second track member is connectable to the first and second outer sheet members and the inner sheet member.
Patent NZ-600212-A (NZ)
Title: Method of handling bananas
Inventor: MIR NAZIR
IPC: A23B7/152
Filed: 2010-12-22
Abstract: Disclosed herein is a method of handling bananas comprising the steps of: exposing said bananas to an atmosphere that contains one or more ethylene active compound selected from the group consisting of ethylene, ethylene release agents, and compounds with high ethylene activity; after said step (a), exposing said bananas to an atmosphere that contains one or more cyclopropene compound at a concentration of 0.5ppb or higher while said bananas have color stage from 2 to 6 on the seven-stage scale; reducing the concentration of said cyclyopropene compound in the atmosphere surrounding said bananas to below 0.5ppb; and after step (c), keeping said bananas in a modified atmosphere package for at least one continuous hour; wherein said step (d) begins up to 72 hours from said step (c), and wherein said modified-atmosphere package is constructed so that the transmission rate of carbon dioxide for the entire package (PCT) is from 2,400 to 120,000 cubic centimetres per day per kilogram of said bananas.
Patent NZ-601278-A (NZ)
Title: Inhibitors of Bruton's tyrosine kinase
Inventor: HONIGBERG LEE
IPC: A01N43/90
Filed: 2006-12-28
Abstract: 601278 Disclosed are pyrazolo-pyrimidin derivatives of formula (D) that form covalent bonds with Bruton's tyrosine kinase (Btk), wherein the variables shown in the structure of formula (D) are as defined in the specification. Also described are irreversible inhibitors of Btk; methods for the preparation of these compounds; and pharmaceutical compositions that include the compounds. These Btk inhibitors are suitable for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions. Examples of compounds of formula (D) are: 1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-yn-1-one; N-((1s,4s)-4-(4-amino-3-(4-phenoxyphenyl)-1Hpyrazolo[3,4-d]pyrimidin-1-yl)cyclohexyl)propiolamide; 1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)pyrrolidin-1-yl)prop-2-yn-1-one;
Patent NZ-601614-A (NZ)
Title: Gutter support and mounting assembly
Inventor: HIGGINS IAN JOHN
IPC: E04D13/072
Filed: 2008-01-11
Abstract: A system for supporting a channel-shaped gutter on an upright surface (300) of a building, the system comprising: a support assembly (210) for attachment at the building, the support assembly being further adapted for receiving and mounting the gutter thereat; and a plurality of spacers (230), the spacers being arranged to locate between the support assembly and the upright surface to provide an overflow gap between the upright surface and the gutter. The spacers may be formed separately to the support assembly and the gutter, or amy be integrally formed with the support assembly.
Patent NZ-603328-A (NZ)
Title: Process for refining chemicals from pulp and paper mill wastewaters
Inventor: MACLATCHY DEBORAH L
IPC: C02F1/04
Filed: 2011-04-07
Abstract: Disclosed herein a process for isolating at least one target compound, such as manool, geranyl linalool, ethyl guaiacol, eugenol, veratraldehyde, squalene, terpin, cholesterol, beta-sitosterol, campesterol, stigmasterol, stigmastenol and dehydroabietic acid, from biomass, the process including steps of: obtaining a condensate from a recovery evaporator, a reverse osmosis retentate of a condensate of a pulp and paper mill, or both, the condensate, retentate or both being substantially free of higher molecular weight (approximately >1000 Da) cellulose and/or lignin and/or lignin-derived material; centrifuging the condensate or RO retentate to collect water insoluble material; extracting the insoluble material with solid-liquid extraction to produce an extract containing the at least one target compound; and optionally purifying the extract containing the at least one target compound by thermal fractionation, chromatographic separation, recrystallization ion exchange, chelation, adsorption/desorption, lyophilization and sublimation or combinations thereof. The method is particularly useful for isolating the target compounds from wastewaters produced in a kraft pulp and paper mill.
Patent NZ-610040-A (NZ)
Title: A centrifugal separator, wear resistance member and set of wear resistance members for a centrifugal separator
Inventor: LENDZIAN WILLI B
IPC: B04B1/00
Filed: 2011-11-10
Abstract: A centrifugal separator comprises a bowl with a conical part (17) with a narrow discharge end (15) comprising a radial surface (19); an end member (21) opposite the radial surface; a number of distance members extending between the radial surface and the end member and providing outlet openings (10) between adjacent distance members; and wear resistance members covering surfaces at the outlet openings. The wear resistance members comprise bushing members (29) with mantle portions (31) surrounding respective distance members.
Patent NZ-623683-A (NZ)
Title: Non-aqueous liquid concentrate for aqueous dispersion
Inventor: PALAIKIS LIANA VICTORIA
IPC: A62D1/00
Filed: 2012-10-05
Abstract: A non-aqueous liquid concentrate comprising starch, an acrylic acid homopolymer salt, vegetable oil, and clay. The non-aqueous liquid concentrate forms an aqueous dispersion when added to water and is capable of clinging to a surface. Also disclosed are methods of forming the an aqueous dispersion by adding the non-aqueous liquid concentrate to water and methods of applying the aqueous dispersion to a substrate to suppress a fire. In particular embodiments the acrylic acid homopolymer salt is: Carboxyvinyl homopolymer salt, polyacrylate homopolymer salt or 2 propenoic homopolymer salt
Patent NZ-631715-A (NZ)
Title: Dynamic currency conversion transaction system
Inventor: SUNIL SHARMA
IPC: G06Q20/30
Filed: 2014-03-14
Abstract: The invention disclosed is a computer implemented method of performing a payment device transaction between a payment device holder and a merchant. The steps include, obtaining a transaction amount of the transaction in a merchant’s currency, and then obtaining an issuer currency from data present on the payment device, using several direct or indirect techniques. If an issuer currency is found and is not the same as the merchant currency then the transaction amount is converted to the issuer currency using an exchange rate source. If no data can be extracted from the payment device, then equivalent amounts in a range of currencies to the transaction amount are obtained and displayed for the user to choose from. Against each currency displayed is a graphic that uniquely identifies each currency. A transaction currency can then be chosen and the transaction completed.
Patent NZ-712124-A (NZ)
Title: Water temperature regulating valve
Inventor: FORRESTAL DAVID PETER
IPC: G05D23/13
Filed: 2014-03-12
Abstract: The invention relates to a fluid temperature regulating valve suitable for use in, for example, hydronic heating systems. In hydronic heating systems, the role of a fluid temperature regulating valve is to (1) receive high temperature fluid from a boiler or similar heated fluid source; (2) receive lower temperature fluid returning from heating loops of the hydronic heating system (or in other applications the valve may receive lower temperature fluid returning from some other apparatus that has used the fluid mixed by the valve e.g. for heating); (3) output fluid at a constant temperature to the heating loops of the hydronic heating system (or other apparatus in other applications) by regulating the relative flow rates of the high and lower temperature fluid through the valve; and (4) ensuring that any additional fluid added to the hydronic heating system from the boiler or other heated fluid source is replaced by a corresponding amount of water being returned to the boiler or similar heated fluid source. The valve may also provide overall temperature control, e.g. in the case of hydronic heating systems, so as prevent damage to floor structures or floor coverings. Traditionally, in these types of fluid temperature regulating valves, the required flow passages to direct the high temperature fluid and lower temperature fluid to regulating gaps are formed by cast or mechanical channels within a brass valve body. The invention provides an insert, typically made from a polymer, having a central bore and also defining flow passages configured to direct the flows of hot and cooled fluid entering the valve. The flow passages defined by the insert interact with other temperature-reactive components in the valve to permit, restrict or prevent the flows of hot fluid and cooled fluid into the valve, and mixed fluid and return fluid out of the valve. The insert maintains a substantially fixed position with the inner surface of the valve body and provides a seal therebetween.